Index 945
diagnostic criteria for, 110–111
diagnostic features of, 112–113
diagnostic markers for, 114
differential diagnosis of, 114–115
functional consequences of, 114
prevalence of, 113
recording procedures for, 112
Substance/medication-induced sexual 
dysfunction, 423, 446–450
associated features supporting diagnosis of, 
448–449
culture-related diagnostic issues in, 449
development and course of, 449
diagnostic criteria for, 446–447
diagnostic features of, 448
differential diagnosis of, 450
functional consequences of, 450
gender-related diagnostic issues in, 449
prevalence of, 449
recording procedures for, 447–448
Substance/medication-ind uced sleep disorder, 
413–420
associated features supporting diagnosis of, 
416–418
comorbidity with, 420
culture-related diagnostic issues in, 418
development and course of, 418
diagnostic criteria for, 413–415
diagnostic features of, 416
diagnostic markers for, 419
differential diagnosis of, 419–420
functional consequences of, 419
gender-related diagnostic issues in, 418
recording procedures for, 415–416
relationship to International Classification of 
Sleep Disorders, 420
risk and prognostic factors for, 418
Substance-related and addictive disorders, 
481–589
gambling disorder, 481, 585–589
highlights of changes fr om DSM-IV to DSM-5, 
815
substance-related disorders, 481–585 ( See also  
specific substances of abuse )
alcohol-related disorders, 490–503
caffeine-related disorders, 503–509